|
ZC3H4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.224300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.04229999999961E-05 |
| Normal-vs-Stage2 |
8.351400E-01 |
| Normal-vs-Stage3 |
1.037050E-01 |
| Normal-vs-Stage4 |
5.037600E-01 |
| Stage1-vs-Stage2 |
7.463700E-03 |
| Stage1-vs-Stage3 |
1.370260E-02 |
| Stage1-vs-Stage4 |
1.320030E-03 |
| Stage2-vs-Stage3 |
2.548600E-01 |
| Stage2-vs-Stage4 |
7.373400E-01 |
| Stage3-vs-Stage4 |
3.421600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.721200E-03 |
| Normal-vs-AfricanAmerican |
2.402400E-02 |
| Normal-vs-Asian |
1.037250E-03 |
| Caucasian-vs-AfricanAmerican |
3.459200E-01 |
| Caucasian-vs-Asian |
2.922500E-02 |
| AfricanAmerican-vs-Asian |
1.927370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.743770E-02 |
| Normal-vs-Female |
1.781160E-03 |
| Male-vs-Female |
2.292600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.858430E-02 |
| Normal-vs-Age(41-60Yrs) |
8.18220000000647E-05 |
| Normal-vs-Age(61-80Yrs) |
1.329640E-01 |
| Normal-vs-Age(81-100Yrs) |
1.065390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.953000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.755500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.902900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.175880E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.963900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.888210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.13680000360483E-08 |
| Normal-vs-Grade 2 |
6.212400E-04 |
| Normal-vs-Grade 3 |
8.141700E-02 |
| Normal-vs-Grade 4 |
5.674800E-01 |
| Grade 1-vs-Grade 2 |
1.103540E-03 |
| Grade 1-vs-Grade 3 |
2.2779999999667E-06 |
| Grade 1-vs-Grade 4 |
1.46129999989419E-07 |
| Grade 2-vs-Grade 3 |
4.168300E-02 |
| Grade 2-vs-Grade 4 |
5.102100E-03 |
| Grade 3-vs-Grade 4 |
2.509000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.29790000000941E-05 |
| Normal-vs-ccB subtype |
1.153390E-01 |
| ccA subtype-vs-ccB subtype |
7.918300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.912300E-02 |
| Normal-vs-N1 |
5.466600E-01 |
| N0-vs-N1 |
7.127000E-01 |
|
|
